Lovastatin-induced apoptosis in thyroid cells: Involvement of cytochrome c and lamin B

European Journal of Endocrinology

Volumn 145, Issue 5, 2001, Pages 645-650

  Di Matola, T ^a   D'Ascoli, F ^a   Luongo, C ^a   Bifulco, M ^a   Rossi, G ^a   Fenzi, G ^a   Vitale, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 2; CASPASE 3; CASPASE 6; CYTOCHROME C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMIN B; MEVINOLIN; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; PROTEINASE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CULTURE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CENTRIFUGATION; CONTROLLED STUDY; CYTOSOL; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; FETUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYROID CELL; THYROID DISEASE; WESTERN BLOTTING;

EID: 0035168706     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450645     Document Type: Article

References (24)

1. Lovastatin-induced apoptosis in prostate stromal cells
2. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts
3. Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment
4. Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism
5. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells
6. Chemical biology of protein isoprenylation/methylation
7. Inhibition of Ras prenylation: A novel approach to cancer chemotherapy
8. Inhibition of Ras prenylation: A signaling target for novel anti-cancer drug design
9. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP
10. Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin
11. Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells
12. Caspase structure, proteolytic substrates, and function during apoptotic cell death
13. Caspases: Intracellular signaling by proteolysis
14. Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases
15. The caspase family of cysteine proteases
16. Human ICE/CED-3 protease nomenclature
17. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 Fas/APO-1 death-inducing signaling complex
18. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
19. Fibronectin is required to prevent thyroid cell apoptosis through an integrin-mediated adhesion mechanism
20. Inactivation of Bcl-2 by phosphorylation
21. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis
22. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
23. PKC-delta is an apoptotic lamin kinase
24. Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: Comparison with FRTL-5 cells